Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06824818 · ClinicalTrials.gov registry record · NA

Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients

A NA study of Prostate Cancer and Elderly, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
155
Enrollment target
2
Study locations

NCT06824818 is a NA study of Prostate Cancer and Elderly that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 155 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06824818, a NA study of Prostate Cancer and Elderly, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
155 participants
Enrollment target
2
Study locations

Study Summary

This study seeks to identify if it is feasible to stop Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Therapy in elderly men with prostate cancer. We hypothesize that elderly prostate cancer patients on long term androgen ablation with LHRH agonists will be permanently castrated and do not require ongoing LHRH agonist therapy. Participants will be monitored by testosterone testing throughout study.

Conditions Studied

Prostate Cancer Elderly

Interventions

  • BEHAVIORAL LHRH Agonist Therapy Discontinuation

Study Locations (2)

Illinois

  • The University of Illinois at Chicago (UIC) - Chicago
  • UChicago Medicine Comprehensive Cancer Center - Chicago

Trial Details

FieldValue
Enrollment Target 155 participants
Start Date 2026-06
Est. Completion 2027-06
Phase NA

Sponsor

University of Chicago

796 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06824818

The ClinicalTrials.gov registry entry for NCT06824818 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (75% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which LHRH Agonist Therapy Discontinuation is the first listed.

NCT06824818 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06824818 about?

NCT06824818 is a clinical study titled "Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients". This study seeks to identify if it is feasible to stop Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Therapy in elderly men with prostate cancer. We hypothesize that elderly prostate cancer patients on long term androgen ablation with LHRH agonists will be permanently castrated and do not req...

What is the current status of trial NCT06824818?

This trial is currently recruiting. It is a NA study. The enrollment target is 155 participants. The study started on 2026-06. Estimated completion is 2027-06.

What conditions does trial NCT06824818 study?

This clinical trial studies the following conditions: Prostate Cancer, Elderly.

What interventions are being tested in trial NCT06824818?

The interventions under investigation include: LHRH Agonist Therapy Discontinuation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06824818?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06824818 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Elderly

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.